Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence.

Mason BJ, Salvato FR, Williams LD, Ritvo EC, Cutler RB.

Arch Gen Psychiatry. 1999 Aug;56(8):719-24.

PMID:
10435606
2.

The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking.

Pettinati HM, O'Brien CP, Rabinowitz AR, Wortman SP, Oslin DW, Kampman KM, Dackis CA.

J Clin Psychopharmacol. 2006 Dec;26(6):610-25. Review.

PMID:
17110818
3.

Opioid antagonists for alcohol dependence.

Srisurapanont M, Jarusuraisin N.

Cochrane Database Syst Rev. 2000;(3):CD001867. Review. Update in: Cochrane Database Syst Rev. 2002;(2):CD001867.

PMID:
10908513
4.

Opioid antagonists for alcohol dependence.

Rösner S, Hackl-Herrwerth A, Leucht S, Vecchi S, Srisurapanont M, Soyka M.

Cochrane Database Syst Rev. 2010 Dec 8;(12):CD001867. doi: 10.1002/14651858.CD001867.pub2. Review.

PMID:
21154349
5.

Opioid antagonists for pharmacological treatment of alcohol dependence - a critical review.

Soyka M, Rösner S.

Curr Drug Abuse Rev. 2008 Nov;1(3):280-91. Review.

PMID:
19630726
6.
7.
8.

Pharmacotherapy of alcohol dependence: a review of the clinical data.

Mann K.

CNS Drugs. 2004;18(8):485-504. Review.

PMID:
15182219
9.

Risks and Benefits of Nalmefene in the Treatment of Adult Alcohol Dependence: A Systematic Literature Review and Meta-Analysis of Published and Unpublished Double-Blind Randomized Controlled Trials.

Palpacuer C, Laviolle B, Boussageon R, Reymann JM, Bellissant E, Naudet F.

PLoS Med. 2015 Dec 22;12(12):e1001924. doi: 10.1371/journal.pmed.1001924. eCollection 2015 Dec. Review.

10.

Naltrexone in the treatment of alcoholism: a clinical review.

O'Brien CP, Volpicelli LA, Volpicelli JR.

Alcohol. 1996 Jan-Feb;13(1):35-9. Review.

PMID:
8837932
11.

Nalmefene: a review of its use in the treatment of alcohol dependence.

Keating GM.

CNS Drugs. 2013 Sep;27(9):761-72. doi: 10.1007/s40263-013-0101-y. Review.

PMID:
23949908
13.

Nalmefene for Reducing Alcohol Consumption in People with Alcohol Dependence: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Stevenson M, Pandor A, Stevens JW, Rawdin A, Rice P, Thompson J, Morgan MY.

Pharmacoeconomics. 2015 Aug;33(8):833-47. doi: 10.1007/s40273-015-0272-0. Review.

PMID:
25851485
14.
15.

Dosing issues in the pharmacotherapy of alcoholism.

Mason BJ.

Alcohol Clin Exp Res. 1996 Oct;20(7 Suppl):10A-16A. Review.

PMID:
8904989
16.

Naltrexone depot formulations for opioid and alcohol dependence: a systematic review.

Lobmaier PP, Kunøe N, Gossop M, Waal H.

CNS Neurosci Ther. 2011 Dec;17(6):629-36. doi: 10.1111/j.1755-5949.2010.00194.x. Review.

PMID:
21554565
17.

Nalmefene: a long-acting opioid antagonist. Clinical applications in emergency medicine.

Wang DS, Sternbach G, Varon J.

J Emerg Med. 1998 May-Jun;16(3):471-5. Review.

PMID:
9610980
18.
19.
20.

A risk-benefit assessment of naltrexone in the treatment of alcohol dependence.

Berg BJ, Pettinati HM, Volpicelli JR.

Drug Saf. 1996 Oct;15(4):274-82. Review.

PMID:
8905252

Supplemental Content

Support Center